US OptionsDetailed Quotes
GLUE241220P20000
- 0.00
- 0.000.00%
15min DelayTrading Nov 26 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover258.49%IV-127.27%PremiumDec 20, 2024Expiry Date11.20Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8178Delta0.0462Gamma0.76Leverage Ratio-0.0303Theta-0.0090Rho-0.62Eff Leverage0.0060Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet